Interim Clinical Considerations for Use of COVID-19 Vaccines Appendices References and Previous Updates
Centers for Disease Control and Prevention.
(2023).
Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates.
(Added 12/30/2020.) U.S. Department of Health and Human Services.
This page offers clinical considerations for the Pfizer-BioNTech, Moderna, Novavax, and Johnson & Johnson/Janssen COVID-19 vaccines related to updated vaccination of those who previously received a COVID-19 vaccine outside the United States and vaccine administration errors and deviations.
Favorite:
Login to rate, favorite, and comments
on the article
Comments
0
Toggle Open/Close
You must Login to add a comment
- This item doesn't have any comments